Germline BRCA1 and BRCA2 testing for breast cancer survivors

Background For patients with early breast cancer, knowledge of germline BRCA1 / 2 status increasingly influences management as well as informing future cancer risk for patients and their families. As access to germline testing expands, it is important that this benefit is extended to survivors as well as to the newly diagnosed. Methods In collaboration with our breast unit colleagues and by embedding a Senior Genetic Counsellor in the virtual...